98%
921
2 minutes
20
Psychiatric diagnosis is formulated by symptomatic classification; disease-specific neurophysiological phenotyping could help with its fundamental treatment. Here, we investigated brain phenotyping in patients with schizophrenia (SZ) and major depressive disorder (MDD) by using electroencephalography (EEG) and conducted machine-learning-based classification of the two diseases by using EEG components. We enrolled healthy controls (HCs) ( = 30) and patients with SZ ( = 34) and MDD ( = 33). An auditory P300 (AP300) task was performed, and the N1 and P3 components were extracted. Two-group classification was conducted using linear discriminant analysis (LDA) and support vector machine (SVM) classifiers. Positive and negative symptoms and depression and/or anxiety symptoms were evaluated. Considering both the results of statistical comparisons and machine learning-based classifications, patients and HCs showed significant differences in AP300, with SZ and MDD showing lower N1 and P3 than HCs. In the sum of amplitudes and cortical sources, the findings for LDA with classification accuracy (SZ vs. HCs: 71.31%, MDD vs. HCs: 74.55%), sensitivity (SZ vs. HCs: 77.67%, MDD vs. HCs: 79.00%), and specificity (SZ vs. HCs: 64.00%, MDD vs. HCs: 69.67%) supported these results. The SVM classifier showed reasonable scores between SZ and HCs and/or MDD and HCs. The comparison between SZ and MDD showed low classification accuracy (59.71%), sensitivity (65.08%), and specificity (54.83%). Patients with SZ and MDD showed deficiencies in N1 and P3 components in the sum of amplitudes and cortical sources, indicating attentional dysfunction in both early and late sensory/cognitive gating input. The LDA and SVM classifiers in the AP300 are useful to distinguish patients with SZ and HCs and/or MDD and HCs.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8549692 | PMC |
http://dx.doi.org/10.3389/fpsyt.2021.745458 | DOI Listing |
J Affect Disord
September 2025
Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Beijing, China. Electronic address:
Background: This study aimed to examine associations between age of onset and domain-specific cognitive deficits in major depressive disorder (MDD).
Methods: We assessed 582 MDD patients (389 first-episode [FED], 193 recurrent [RMD]) and 280 healthy controls (HCs) using five cognitive domains from the MATRICS Consensus Cognitive Battery. Of these patients, 289 were reassessed after 8 weeks of antidepressant treatment.
Depress Anxiety
September 2025
Medical Imaging Center, First Affiliated Hospital of Jinan University, Guangzhou, China.
The therapeutic effects of vortioxetine on mood and cognition have been documented in major depressive disorder (MDD). This study aims to examine whether vortioxetine can improve brain glymphatic system function and connections among functional brain networks and to explore the underlying relationships among these changes. A total of 34 patients with MDD and 41 healthy controls (HCs) were recruited in the study.
View Article and Find Full Text PDFJ Affect Disord
September 2025
Health Management Center, Xiangya Hospital, Central South University, Changsha, China. Electronic address:
Background: Evidence demonstrated that frontostriatal disruption may result in anhedonia in major depressive disorder (MDD). However, limited research examined the correlations of frontostriatal connectivity and anhedonia, especially in first-episode, treatment-naïve major depressive disorder.
Method: Resting-state functional magnetic resonance imaging (rs-fMRI) was obtained from 44 first-episode, treatment-naïve young adult patients with MDD and 50 healthy controls (HCs).
Depress Anxiety
September 2025
School of Electronic and Information Engineering, Kunsan National University, Gunsan, Republic of Korea.
Major depressive disorder (MDD) and schizophrenia (SZ) are among the most debilitating psychiatric disorders, characterized by widespread disruptions in large-scale brain networks. However, the commonalities and distinctions in their large-scale network distributions remain unclear. The present study aimed to leverage advanced deep learning techniques to identify these common and distinct patterns, providing insights into the shared and disorder-specific neural mechanisms underlying MDD and SZ.
View Article and Find Full Text PDFPsychol Med
September 2025
Department of Breast Disease, Henan Breast Cancer Center, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital.
Background: Neuroimaging studies provide compelling evidence that major depressive disorder (MDD) is associated with widespread gray matter morphological abnormalities. However, significant interindividual variability complicates the interpretation of group-level findings, highlighting the need for investigating potential MDD subtypes.
Methods: In this study, we aimed to identify subtypes of MDD based on individualized deviations from normative gray matter volumes (GMVs), as estimated using a normative model derived from healthy controls (HCs).